Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Autoimmune Diseases · Autoimmune Diseases of the Nervous System · Neuromyelitis Optica Spectrum Disorder · Myasthenia Gravis · Chronic Inflammatory Demyelinating Polyradiculoneuropathy · Idiopathic Inflammatory Myopathies · Multiple Sclerosis · Autoimmune Encephalitis · Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) · POEMS Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China
Contact: Principal Investigator (Wei Wang, MD)Bitao Bu, MD (Sub-investigator)Min Zhang, MD (Sub-investigator)Daishi Tian, MD (Sub-investigator)Chuan Qin, MD (Sub-investigator)Jianfeng Zhou, MD (Sub-investigator)Chunrui Li, MD (Sub-investigator)Di Wang, MD (Sub-investigator)
Study leads
Wei Wang, MD
Principal Investigator
Tongji Hospital